Chairman's message


I am pleased to announce that Julphar has closed the year 2014 at AED1.433 billion, producing overall steady results, with a year-on-year growth of 5.2% over sales from 2013.

Julphar is a proud Emirati Company with great ambitions to thrive in International markets and this remains at the heart of our business. A key priority is to identify opportunities which will create long-term value for our Shareholders and enable us to provide quality, affordable medicines to people now and in future generations.

I would like to congratulate the Julphar Executive team for their leadership abilities, producing sustainable returns and focusing on developing a skilled National work force through our Emiratisation Program and Absher initiative.

As the global Healthcare market continues to grow at a tremendous rate, we extend our thanks to the Government, our Customers, Employees, our well-wishers, Board of Directors and all other stakeholders for their wholehearted and continued support and contribution in the success of Julphar.


Sheikh Faisal Bin Saqr Al Qasimi


This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.